← Insider buys
TERN

Terns Pharmaceuticals, Inc. · Healthcare

Chief Medical Officer Emil Kuriakose sold $45K of Terns Pharmaceuticals, Inc.

Sold$44,552
$38.57Price
1,155Shares
−2%Stake

What TERN did after the filing

Filed Jan 6Copier in Jan 7
The stock from Wed, Jan 7 open, $37.89
+3.5%
S&P 500, same days
−0.4%

Measured over 30 trading days, to the Feb 20 close.

Traded Fri, Jan 2. Filed Tue, Jan 6, 8:25 PM ET, after the close. Returns use the Jan 7 open and the Feb 20 close. Not investment advice.